6PQ8 image
Entry Detail
PDB ID:
6PQ8
Title:
Crystal structure of TLA-1 S70G extended spectrum Beta-lactamase in complex with clavulanic acid
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2019-07-08
Release Date:
2019-12-11
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Beta-lactamase
Mutations:S70G
Chain IDs:A
Chain Length:299
Number of Molecules:1
Biological Source:Escherichia coli
Primary Citation
The crystal structure of ESBL TLA-1 in complex with clavulanic acid reveals a second acylation site.
Biochem.Biophys.Res.Commun. 522 545 551 (2020)
PMID: 31780261 DOI: 10.1016/j.bbrc.2019.11.138

Abstact

β-lactamases are the main molecules responsible for giving bacterial resistance against β-lactam antibiotics. The study of β-lactamases has allowed the development of antibiotics capable of inhibiting these enzymes. In this context, extended spectrum β-lactamase (ESBL) TLA-1 has spread in Escherichia coli and Enterobacter cloacae clinical isolates during the last 30 years in Mexico. In this research, the 3D structures of ESBL TLA-1 and TLA-1 S70G mutant, both ligand-free and in complex with clavulanic acid were determined by X-ray crystallography. Four clavulanic acid molecules were found in the structure of TLA-1, two of those were intermediaries of the acylation process and were localized covalently bound to two different amino acid residues, Ser70 and Ser237. The coordinates of TLA-1 in complex with clavulanic acid shows the existence of a second acylation site, additional to Ser70, which might be extendable to several members of the subclass A β-lactamases family. This is the first time that two serines involved in binding clavulanic acid has been reported and described to an atomic level.

Legend

Protein

Chemical

Disease

Primary Citation of related structures